Gryphon Financial Partners LLC Teva Pharmaceutical Industries LTD Transaction History

Gryphon Financial Partners LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 07, 2019	SELL	$15.58 - $20.01 $436,208 - $560,239	-27,998 Closed	0 $0
Q4 2018 Feb 11, 2019	BUY	$14.59 - $23.84 $408,490 - $667,472	27,998 New	27,998 $684,000
Q3 2018 Nov 06, 2018	SELL	$21.06 - $25.65 $4,275 - $5,206	-203 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$16.77 - $24.71 $972 - $1,433	58 Added 40.0%	203 $5,000
Q1 2018 May 14, 2018	SELL	$16.68 - $22.07 $6,672 - $8,828	-400 Reduced 73.39%	145 $3,000
Q4 2017 Feb 09, 2018	BUY	$11.23 - $19.1 $6,120 - $10,409	545	545 $10,000

640

580M

19.6M

6.77M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $19.1B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of Gryphon Financial Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Gryphon Financial Partners LLC with notifications on news.